Monopar Therapeutics Inc. (MNPR) has a MoatMap StockRank of 7/100 based on Quality (45/100), Value (29/100), and Momentum (15/100) factor scores. The current signal is STRONG SELL. Monopar Therapeutics Inc., a healthcare company, does not exhibit a clear or powerful asymmetric opportunity driven by the identified macro themes of energy, trade, or critical materials. Its business model is largely disconnected from these external factors.